Weight loss
Tesofensine
Triple monoamine reuptake inhibitor studied for appetite and body weight.
- Third-party tested
- EU shipping · discreet delivery, free over €459.99
- Card, Apple Pay, Google Pay or crypto
Overview
Tesofensine blocks the reuptake of three brain messengers at once: serotonin, noradrenaline and dopamine. It was first developed for Parkinson's and Alzheimer's disease.
In those early trials, researchers noticed weight loss as a side effect, which led to dedicated obesity studies on appetite and energy balance.
Research areas
- Appetite and satiety regulation in the brain
- Body-weight regulation
- Monoamine neurotransmitter pharmacology
Specifications
- Category
- Weight loss
- Compound
- Small molecule, serotonin / noradrenaline / dopamine reuptake inhibitor
- Structure
- Not a peptide
- Form
- Capsules
- Available as
- 500mcg (100 caps)
- Quality
- Third-party tested
Storage and handling
Store in the closed container in a cool, dry place below 25 °C, away from light.
Sold strictly for laboratory research use only. Not for human consumption, and not intended to diagnose, treat, cure or prevent any disease.